By Frank Prenesti
Date: Monday 21 Jul 2025
(Sharecast News) - US healthcare company Johnson & Johnson raised on Wednesday annual earnings and sales guidance on the back of strong sales and foreign exchange tailwinds, sending shares in the firm up 5.5%.
Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
Currency | US Dollars |
Share Price | $ 174.31 |
Change Today | $ -0.11 |
% Change | -0.06 % |
52 Week High | $174.67 |
52 Week Low | $142.06 |
Volume | 2,999,773 |
Shares Issued | 2,406.92m |
Market Cap | $419,551m |
Beta | 0.06 |
RiskGrade | 87 |
Strong Buy | 6 |
Buy | 5 |
Neutral | 14 |
Sell | 0 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
12:41 | 100 @ $174.31 |
12:41 | 100 @ $174.31 |
12:41 | 100 @ $174.32 |
12:41 | 100 @ $174.32 |
12:41 | 100 @ $174.33 |
You are here: research